Clinical Trial Update: Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating doxorubicin and paclitaxel for locally advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Georgetown University | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED